Long overall survival blood cancer patients showed higher levels of Tregs, plasma cells, CD8+ and B naïve cells whereas short overall survival blood cancer patients showed higher levels of M2 macrophages, B memory cells, T follicular helper cells and γδ T cells (Fig 9C; S6 Table). The gene discussed is CD8A; the disease is cancer.